惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博
博客园_首页
J
Java Code Geeks
博
博客园 - 聂微东
量
量子位
C
Check Point Blog
T
The Blog of Author Tim Ferriss
T
Tailwind CSS Blog
G
Google Developers Blog
Google DeepMind News
Google DeepMind News
B
Blog
罗
罗磊的独立博客
腾
腾讯CDC
GbyAI
GbyAI
博
博客园 - 【当耐特】
A
About on SuperTechFans
M
MIT News - Artificial intelligence
U
Unit 42
D
Docker
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
Y
Y Combinator Blog
大猫的无限游戏
大猫的无限游戏
小众软件
小众软件
S
SegmentFault 最新的问题
有赞技术团队
有赞技术团队

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings C...
2026-05-08 · via All Articles on Seeking Alpha

Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDT

Company Participants

Gayathri Diwakar - Senior Director of Investor Relations
R. Struthers - Founder, President, CEO & Director
Isabel Kalofonos - Chief Commercial Officer
Alan Krasner - Chief Endocrinologist
Tobin Schilke - Chief Financial Officer

Conference Call Participants

Joseph Schwartz - Leerink Partners LLC, Research Division
Gavin Clark-Gartner - Evercore ISI Institutional Equities, Research Division
Maxwell Skor - Morgan Stanley, Research Division
Jonathan Wolleben - Citizens JMP Securities, LLC, Research Division
Jessica Fye - JPMorgan Chase & Co, Research Division
Yuchen Ding - Jefferies LLC, Research Division
Katherine Kaiser-Dellorusso - LifeSci Capital, LLC, Research Division
Alexander Thompson - Stifel, Nicolaus & Company, Incorporated, Research Division
Nicholas Lorusso - TD Cowen, Research Division
Douglas Tsao - H.C. Wainwright & Co, LLC, Research Division
Jin Law - Goldman Sachs Group, Inc., Research Division
Catherine Novack - JonesTrading Institutional Services, LLC, Research Division
Brian Skorney - Robert W. Baird & Co. Incorporated, Research Division

Presentation

Operator

Hello, everyone. Thank you for joining us, and welcome to the Crinetics Pharmaceuticals First Quarter 2026 Financial Results. [Operator Instructions] I will now hand the conference over to Gayathri Diwakar, Head of Investor Relations. Gayathri, please go ahead.

Gayathri Diwakar
Senior Director of Investor Relations

Thank you, operator. Good afternoon, everyone, and thank you for joining us to discuss the first quarter 2026 results. Today on the call, we have Dr. Scott Struthers, Founder and Chief Executive Officer; Isabel Kalofonos, Chief Commercial Officer; Dr. Alan Krasner, Chief Endocrinologist; and Tobin Schilke, Chief Financial Officer.

Please note, there is a slide deck for today's presentation, which is in the Events and Presentations section of the Investors page on the Crinetics website. In addition, a press release was issued earlier today and is also available on the corporate website.

Slide 2. As a reminder, we'll be making forward-looking statements, and I invite

此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。